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Abstract: The cytokine network is one of the major con-
trolling systems of the inﬂammatory process, driving the
magnitude and duration of the host response against invad-
ing microorganisms, foreign materials, or altered internal
stimuli. Pro- and antiinﬂammatory cytokines were quanti-
ﬁed after in vitro culture of a mixed population of mono-
cytes/macrophages and lymphocytes with biodegradable
polymers. Different blends of starch-based polymers and
their composites ﬁlled with hydroxyapatite were studied
and compared with poly-L-lactide. Interleukin (IL)-1, IL-6,
and tumour necrosis factor-were investigated as the mark-
ers of immunological reactivity because they are known to
act at the early stages of injury/invasion. Interferon-, rec-
ognized as a proinﬂammatory cytokine, although not
present during early responses was also investigated. Con-
trarily, IL-4 derived from T lymphocytes, was investigated
because it is an immunoregulator that counteracts some
aspects of inﬂammation. T lymphocyte activation was also
determined by quantifying IL-2. The results support the
hypothesis that different biodegradable polymers can affect
mononuclear cell activation and the production of several
cytokines associated with the inﬂammatory process. No IL-2
or interferon-was found in the culture supernatants after 3,
7, and 14 days in the presence of any of the materials. IL-6
was detected in the highest amounts, for all the conditions,
followed by tumour necrosis factor-. IL-1 was produced
in very low amounts, being undetectable with some of the
starch-based materials. IL-4 was the only cytokine that did
not demonstrate any signiﬁcant difference within this group
of materials. Starch-based polymers and composites induced
lower production of proinﬂammatory cytokines in compar-
ison to poly-L-lactide. © 2004 Wiley Periodicals, Inc.
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INTRODUCTION
It is now recognized that the failure of implanted
medical devices can be associated with several inﬂam-
matory and infectious processes, with the overproduc-
tion of cytokines by persistent leukocytes potentially
being a signiﬁcant inherent factor in these.1–3 Adher-
ent and activated mononuclear cells, monocytes/mac-
rophages, and T lymphocytes produce inﬂammatory
cytokines and chemokines that recruit other inﬂam-
matory cells to the site of implantation.1,4 Further-
more, cytokines may stimulate noninﬂammatory cells
to secrete enzymes and cytokines that will compro-
mise the success of the implant by altering cell phe-
notype and function.5,6
Mononuclear cells comprising monocytes and lym-
phocytes were cultured in vitro to determine the effect
biomaterial surfaces had on the production and re-
lease of interleukin (IL)-1, IL-6, tumor necrosis factor
(TNF)- IL-2, IL-4, and interferon (IFN)- which was
analyzed by enzyme-linked immunosorbent assay
(ELISA). The cytokines were selected considering their
established roles in inﬂuencing the foreign body re-
sponse to implanted materials by controlling local
inﬂammation, cellular activation, and chemotaxis.7,8 It
is recognized that antiinﬂammatory cytokines can also
be present to act to reduce inﬂammation,8 balancing
the effects of proinﬂammatory cytokines and main-
taining homeostasis. IL-4 was investigated as an im-
portant antiinﬂammatory cytokine.
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The in vitro model was composed of different cell
types, which produce speciﬁc cytokines. IL-1 al-
though produced by many different cell types includ-
ing neutrophils, natural killer cells, and B and T lym-
phocytes, is produced in great abundance by blood
monocytes and tissue macrophages.9
Mononuclear phagocytes also produce IL-6, one of
the earliest cytokines of the inﬂammatory process and
a major inducer of acute phase proteins.10,11
Lymphocytes, present in the mononuclear popula-
tion cultured in direct contact with the materials, also
produce IL-6 and IL-1. Nonetheless, IL-2,12 IL-4,13
and IFN-14,15 are speciﬁcally lymphocyte-derived cy-
tokines and their quantiﬁcation can help to determine
the potential roles of lymphocytes in direct contact
with materials.
TNF- is produced in large amounts by activated
mononuclear phagocytes, macrophages, and lympho-
cytes16,17 and for that reason represents a valuable
activation marker.
Besides the induced level of stimulation of each
population of cells, the model enabled the analysis of
interactions between the cytokines themselves. IL-1
is known to have multiple roles in the regulation of
normal tissue repair and chronic inﬂammation. It
stimulates the production of acute phase-reactant pro-
teins11 and has the ability to activate wound healing
cells (ﬁbroblasts), lymphocytes, and monocytes.9,18
IL-6 is a cytokine with pleiotropic activities produced
by a variety of cells including ﬁbroblasts, endothelial
cells, mononuclear phagocytes, neutrophils, hepato-
cytes, and T and B lymphocytes.19 This cytokine can
down-regulate ﬁbroblast and endothelial cell growth
and alternatively it can promote the growth and dif-
ferentiation of monocytes and lymphocytes.19 The
lymphocyte-derived cytokines have signiﬁcant inﬂu-
ence in the monocyte/macrophage population syner-
gizing and/or reducing the effect of the cytokines
produced by those cells. In particular, in response to
IL-2, macrophages will synthesize IL-1 which further
activates T cells to produce more IL-2 to activate more
macrophages in a feed-back cycle.20 IL-4, secreted pre-
dominantly by T helper (Th)-2 lymphocytes,13 inhibits
production of IL-1 and TNF- by activated mono-
cytes.21 IL-4 has also been shown to promote mono-
cyte/macrophage fusion to form foreign body giant
cells.22 IFN- exerts important activities on both
monocyte/macrophage and lymphocytes, which gen-
erally results in macrophage activation and T cell dif-
ferentiation toward a Th-1 type of immune response.23
In this work, the potential of starch-based materials,
previously proposed for a wide range of biomedical
applications,24–27 to induce cytokine production by
mononuclear cells in vitro was investigated and com-
pared with poly-L-lactide (PLLA) (Table I).
MATERIALS AND METHODS
Materials
The materials studied were:
1. a 50:50 (wt %) blend of corn starch and ethylene vinyl
alcohol (SEVA-C) (Novamont, Italy);
2. SEVA-C reinforced with 10%, 20%, and 30% (wt) hy-
droxyapatite (HA) (Plasma Biotal, UK);
3. a 50:50 (wt %) blend of corn starch and cellulose acetate
(SCA) (Novamont, Italy);
4. SCA reinforced with 10%, 20%, and 30% (wt) HA;
5. a 30:70 (wt %) blend of corn starch and polycaprolac-
tone (SPCL) (Novamont, Italy); and
6. SPCL reinforced with 10%, 20%, and 30% (wt) HA.
In the composites, the average size of 90% of the HA
particles was found to be 6.5 m (laser granulometry
analysis).
TABLE I
Cytokine Production at 3-, 7-, and 14-Day Time Periods
Material
IL-4 IL-6 IL-1 TNF- IFN- IL-2
3 7 14 3 7 14 3 7 14 3 7 14 3 7 14 3 7 14
SEVA-C                  
SEVA-C  10% HA                  
SEVA-C  20% HA                  
SEVA-C  30% HA                  
SPCL                  
SPCL  10% HA                  
SPCL  20% HA                  
SPCL  30% HA                  
SCA                  
SCA  10% HA                  
SCA  20% HA                  
SCA  30% HA                  
PS                  
PLLA                  
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PLLA (Purac Biochem BV, The Netherlands), being the
gold standard for biodegradables in biomedical applica-
tions, was used as a biodegradable control material and
polystyrene (PS) coverslips (Sarstedt, UK) as a reference
material.
All the materials were processed into circular samples (
1 cm) by injection molding under optimized processing
conditions.
Mononuclear cell isolation and culture
A mixed population of lymphocytes and monocytes/mac-
rophages was isolated from healthy volunteers. Blood was
layered onto lymphocyte separation medium (LymphoSep;
ICN Biomedicals, Cleveland, OH) and centrifuged at 400g
for 25 min at 4°C. The cell suspension was washed twice
with phospate-buffered saline at 400g for 5 min at 4°C and
the ﬁnal cell concentration controlled and taken into cell
culture conditions with Medium 199 (GIBCO BRL, Rock-
ville, MD) supplemented with 1% antibiotics (Sigma Chem-
ical Co., St. Louis, MO), 10% fetal calf serum (GIBCO BRL
Life Technologies, Rockville, MD), and 0.2% fungizone
(Sigma).
Cells were seeded in direct contact with the polymers for
3, 7, and 14 days at a concentration of 5 104 cells/mL, 1 mL
per well.
Cytokine quantification
After each time period, plates were centrifuged to avoid
cells in suspension and 200 L of the supernatant of each
well was transferred to a new 96-well plate and kept at
80°C, previously shown to be unaffected by up to three
freeze-thaw cycles,28 for analysis using ELISA. The follow-
ing cytokines were quantiﬁed by enzyme immunoassay.
Human IFN-with a minimal detectable dose of4 pg/mL,
human IL-2 with a minimal detectable dose of 5.1 pg/mL,
human IL-4 with a minimal detectable dose of 2.0 pg/mL,
human IL-6 with a minimal detectable dose of 2 pg/mL,
human IL-1 with a minimal detectable dose of 1 pg/mL,
and human TNF- with a minimal detectable dose of 1.7
pg/mL. All ELISA kits were obtained from Biosource Inter-
national, Inc. (Camarillo, CA).
For each cytokine, all samples were tested in duplicate on
each plate and repeated at least three times in independent
experiments except for IFN- and IL-2, which were found to
be undetectable after two experiments and stopped. ELISA
plates were read using a LUCY 1 luminometer plate reader
at wavelength 450 nm (Bio-Stat; Biochem Immunosystems,
Italy). For each measurement, a standard concentration
curve was generated according to the indication of the assay
kit and used to calculate the concentration of released cyto-
kine.
Statistical analysis
The data were statistically analyzed by a one-way analysis
of variance using a Tukey-HDS post hoc test.29 The results
were compared for all the materials at the different times of
culture, and between themselves at each time of culture. If
probability values were 0.05, differences observed were
considered to be statistically signiﬁcant (Tables II–IV) .
RESULTS
IL-6 was detected in the highest amounts, for all the
conditions, followed by TNF-. IL-1was produced in
lower amounts and was undetectable with some of the
starch-based materials. No IL-2 or IFN- was pro-
duced at any of the tested times of culture in the
presence of any of the materials.
There were differences in the amount of released
cytokines with respect to culture time, the amount
decreasing with increasing culture time. In a previous
study,30 the same experimental conditions were used
for the quantiﬁcation of the intracellular lactate dehy-
drogenase of cells adherent to the surface of the ma-
terials. That data showed that the number of adherent
cells varied according to the material, although not
statistically signiﬁcantly. The results demonstrated
that the cytokine production was affected by the ma-
terial and not by the adherent cell number.
IL-4
The amount of IL-4 detected varied between 16 and
29 pg/mL. No signiﬁcant differences were observed
except in the case of SCA  20% HA [Fig. 1(c)]. The
levels of IL-4 tended to increase with the culture pe-
riod in the presence of composites, reaching values
after 7 and 14 days of culture that were statistically
different from those obtained for 3 days of culture.
There was no correlation between the IL-4 released
and the different starch-based blends or with the per-
centage of HA that was reinforcing each of them.
IL-6
In the case of IL-6, the results obtained were com-
plex and inﬂuenced by the type of material and the
presence of ceramic reinforcement. It was possible to
observe that the amount of IL-6 released decreased
with the time of culture for most of the materials
although these differences were not statistically signif-
icant.
IL-6 was the cytokine detected in highest quantity in
the harvested supernatants and varied between about
1200 and 70 pg/mL. PLLA and PS were the two ma-
terials that induced the highest IL-6 release. The re-
sults obtained in the presence of SEVA-C and com-
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posites [Fig. 2(a)] and in the presence of SCA and
composites [Fig. 2(c)], after 3, 7, or 14 days of culture
were found to be statistically different from those
obtained for these two control materials, except SCA
after 7 days (p  0.05 only when compared with PS).
For SPCL and composites [Fig. 2(b)], these materials
induced a release of IL-6 similar to that of PS after 3
days (except SPCL  30% HA) and comparable with
PLLA after 7 days. After 14 days, the levels of IL-6
induced by SPCL and composites reached lower val-
ues, and these were signiﬁcantly different from PS and
PLLA and therefore closer to those obtained for SCA
and composites except in the case of SPCL  20% HA
which was still comparable with PS.
SEVA-C and composites seemed to stimulate less
leukocyte activation [Fig. 2(a)]. The amounts of IL-6
detected in the presence of those materials were
lower than those obtained with any of the other
materials without any differences being measured
between polymer and composites although a de-
crease was observed with increasing HA percent-
ages. After 3 days of culture, these were found to be
statistically different from SPCL and its composites
with 10% HA, 20% HA, and SCA, as well as the
results between SPCL  30% HA and SEVA-C com-
posites, only changing after 7 days when comparing
SEVA-C  30% HA and SCA  20% HA. After 14
days of culture, the results for SEVA and composites
and SCA became closer and only SEVA-C  20%
HA was found to induce signiﬁcant IL-6 production
when compared with SCA. Also when compared
with SPCL, and its composites with 10% HA and
20% HA, only SEVA-C reinforced with 20% HA and
30% HA were found to be different. Furthermore,
TABLE II














HA SCA PS PLLA
3 Days SEVA-C 0 0
SEVA-C  10% HA 0 0
SEVA-C  20% HA 0 0
SEVA-C  30% HA 0 0
SPCL 0.004 0 0 0 0.006
SPCL  10% HA 0.007 0 0 0 0.004
SPCL  20% HA 0 0 0 0 0.045
SPCL  30% HA 0.01 0 0 0.013 0.001
SCA 0.022 0 0.032 0.001
SCA  10% HA 0.012 0.018 0.001 0 0
SCA  20% HA 0.027 0.041 0.003 0 0
SCA  30% HA 0.007 0.011 0.001 0.037 0 0
7 Days SEVA-C 0 0
SEVA-C  10% HA 0 0
SEVA-C  20% HA 0 0
SEVA-C  30% HA 0 0
SPCL 0.017 0 0 0 0.005
SPCL  10% HA 0.007 0 0 0 0.012
SPCL  20% HA 0.011 0 0 0 0.007
SPCL  30% HA 0.001 0 0 0
SCA 0.046 0 0 0 0.002
SCA  10% HA 0.015 0.006 0.010 0.042 0 0
SCA  20% HA 0.050 0.031 0.012 0.021 0 0
SCA  30% HA 0.014 0.006 0.009 0.040 0 0
14
Days SEVA-C 0 0
SEVA-C  10% HA 0 0
SEVA-C  20% HA 0 0
SEVA-C  30% HA 0 0
SPCL 0.032 0.042 0.025 0.010
SPCL  10% HA 0.029 0.038 0.028 0.011
SPCL  20% HA 0.025 0.012 0.016 0.024
SPCL  30% HA 0.007 0.003
SCA 0.041 0.020 0.008
SCA  10% HA 0 0
SCA  20% HA 0 0
SCA  30% HA 0 0
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the SEVA-C  10% HA result was also different
from SPCL  20% HA.
Following SEVA-C and composites, SCA and respec-
tive composites were the materials that induced more
production of IL-6 [Fig. 2(c)]. Again, the same trend, in
terms of the amount of released cytokine and percentage
of HA was observed. However, some statistical differ-
ences were found after 3 days of culture between SCA
and the composite with 30% HA and after 7 days of
culture between SCA and the composites with 10% HA
and 30% HA. Furthermore, at 3 and 7 days of culture, it
was observed that the results in the presence of SCA
composites were different from the results in the pres-
ence of SPCL composites.
In the presence of SPCL and composites, in contrast
with the other starch-based materials, it was possible
to detect and quantify almost three times more IL-6.
The amount of HA did not seem to have any inﬂuence
[Fig. 2(b)].
IL-1
IL-1 production was material dependent and in
some cases with the time of culture. SEVA-C and com-
posites, as well as the SCA composites did not show any
differences with the time of culture. However, SCA and
PS showed signiﬁcant decreases in IL-1 production
with increasing time of culture. The amount of cytokine
released in the presence of SPCL with 10% HA and 20%
HA also showed that tendency, although in the case of
the composite with 10% HA, the difference was only
statistically signiﬁcant after 14 days. IL-1 was detected
in very low amounts after contact with starch-based
materials when compared with the control materials
(Fig. 3). In fact, after 3 and 7 days of culture, all the
materials, except for SCA and SPCL (p 0.05 only when
compared with PS) showed a signiﬁcantly different re-
sult from PS and PLLA. After 14 days of culture, almost
no IL-1 was detected in the supernatants. Comparing
the amounts of IL-1 released in the presence of starch-
based materials after 3 days of culture, SCA induced
production in signiﬁcantly different quantities [Fig. 3(c)].
That difference was only maintained after 7 days of
culture for SEVA-C and SEVA-C composites with 10%
HA and 30%HA [Fig. 3(a)] and for SCA composites [Fig.
3(c)].
After incubation of cells with SPCL composites, HA
was found not to reduce the amount of produced
IL-1, when compared with the non-reinforced poly-
mers. The amount was only different after 3 days and
only between SPCL  20% HA and SEVA-C compos-
ites and SCA  30% HA.
TNF-
The results obtained for TNF- demonstrated sig-
niﬁcant variations according to the type of material, in
some cases also being inﬂuenced by the percentage of
ceramic ﬁller and by the time of culture. Again, as for
IL-6, the general tendency was a reduction in release
with time of culture for most of the materials. For
some of the materials, there were detectable differ-
ences after 7 and 14 days of culture (SEVA-C  10%
HA, PLLA); others only revealed variations in the
amount of cytokine after 14 days in culture (SEVA-C,
SEVA-C  20% HA, SPCL  10% HA and PS).
The level of TNF- detected in the supernatants of
the cultures was between 3 and 190 pg/mL (Fig. 4).
The higher amounts of TNF- were detected in the
presence of PLLA and PS. After 3 days of culture with
all starch-based materials and composites, the released
TNF- was found to be signiﬁcantly different from PS
and PLLA, except for SPCL  30% HA and SCA (p 
0.05 only when compared with PLLA). After 7 days,
differences were observed for SEVA-C and compos-
ites, SPCL, and SCA composites whereas the results
for SPCL reinforced with 10% HA and 30% HA were
similar to PS. After 14 days of culture, only the
SEVA-C composites were found to be different from
the control materials. However, the amount of cyto-
TABLE III
Statistical Summary for IL-1 Expression for Different






HA SCA PS PLLA
3 Days SEVA-C 0 0 0
SEVA-C  10% HA 0.017 0 0 0
SEVA-C  20% HA 0.017 0 0 0
SEVA-C  30% HA 0.049 0 0 0
SPCL 0 0 0
SPCL  10% HA 0 0 0
SPCL  20% HA 0 0 0
SPCL  30% HA 0 0 0
SCA 0 0
SCA  10% HA 0 0 0
SCA  20% HA 0 0 0
SCA  30% HA 0.017 0 0 0
7 Days SEVA-C 0.025 0 0.01
SEVA-C  10% HA 0.010 0 0
SEVA-C  20% HA 0 0.010
SEVA-C  30% HA 0.010 0 0
SPCL 0.022
SPCL  10% HA 0 0.002
SPCL  20% HA 0.001 0.030
SPCL  30% HA 0 0.003
SCA
SCA  10% HA 0.010 0 0
SCA  20% HA 0.020 0 0.01
SCA  30% HA 0.010 0 0
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kine released during contact with SEVA-C, SPCL, and
SCA composites was still different from PLLA.
Analyzing the amount of TNF- in the presence of
SEVA-C and composites, a similar trend to IL-6 was
observed: lower levels were detected when compared
with all the other materials [Fig. 4(a)]. Comparing the
polymer and composites, it was found that the
amount of cytokine released decreased with increas-
ing percentages of HA. Furthermore, after 3 days of
culture, the amount of TNF- detected in the presence
of SEVA-C was found to be signiﬁcantly different for
the result obtained with SEVA-C  30% HA.
Comparing the results obtained for SEVA-C and com-
posites with all the other materials, after 3 and 7 days,
statistically signiﬁcant differences were found with SCA.
After 14 days, only the difference between SEVA-C 
30% HA and SCA remained. SEVA-C composites were
found to be signiﬁcantly different from SPCL composites
after 3 and 7 days, except for SPCL  30% HA after 7
days (p  0.05 only when compared with SEVA-C with
20%HA and 30%HA). The amount of TNF- released in
contact with SEVA-C  30% HA was also found to be
different from the SPCL composite with the same
amount of HA at the 14-day time period.
When comparing all the starch-based materials,
higher amounts of TNF- were released in the pres-
ence of SPCL and composites [Fig. 4(b)]. In this case,
and contrary to SEVA and its composites, increasing
percentages of HA resulted in increasing amounts of
cytokine release. In fact, and in addition to the statis-
tical differences reported after 3 days in culture,
TNF- released in the presence of SPCL was found to
be different from the amount detected in the presence
of SEVA-C with 20% HA and 30% HA.
TABLE IV











HA SCA PS PLLA
3 Days SEVA-C 0.011 0 0
SEVA-C  10% HA 0 0 0
SEVA-C  20% HA 0 0 0
SEVA-C  30% HA 0.017 0 0 0
SPCL 0.033 0.003 0.049 0 0
SPCL  10% HA 0.005 0 0 0.034 0
SPCL  20% HA 0.008 0 0 0.023 0
SPCL  30% HA 0.01 0 0 0.001
SCA 0.007
SCA  10% HA 0.020 0.003 0 0
SCA  20% HA 0.022 0.003 0 0
SCA  30% HA 0.014 0.002 0 0
7 Days SEVA-C 0.021 0 0
SEVA-C  10% HA 0.001 0 0
SEVA-C  20% HA 0 0 0
SEVA-C  30% HA 0 0 0
SPCL 0.010 0.001
SPCL  10% HA 0.045 0.007 0.005 0.028
SPCL  20% HA 0.022 0.003 0.002
SPCL  30% HA 0.009 0.002 0.023
SCA
SCA  10% HA 0.007 0.001
SCA  20% HA 0.014 0.002
SCA  30% HA 0.003 0
14
Days SEVA-C 0.004
SEVA-C  10% HA 0.012 0.001
SEVA-C  20% HA 0.002 0
SEVA-C  30% HA 0.040 0.001 0
SPCL 0.026
SPCL  10% HA
SPCL  20% HA
SPCL  30% HA 0.043
SCA
SCA  10% HA 0.021
SCA  20% HA 0.013
SCA  30% HA 0.014
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Once again, and in agreement with IL-6 quantiﬁca-
tion, the level of TNF- produced in contact with SCA
composites was lower than that detected for SPCL
composites and higher than the amount obtained for
SEVA-C composites. However, in the case of the un-
reinforced polymer (SCA), the amounts detected were
the highest when compared with SEVA-C or SPCL.
Contrary to any of the other starch-based blends,
the presence of HA in the starch blend with cellulose
acetate induced a decrease in the amount of TNF-
production, although the percentage of ceramic had
Figure 1. IL-4 release from monocytes/macrophages and
lymphocytes when in culture with (a) SEVA-C and respec-
tive composites with HA and PS, (b) SPCL and respective
composites with HA and PLLA, (c) SCA and respective
composites with HA, for 3, 7, and 14 days. Data represent
mean 	 standard deviation, n  3. Signiﬁcant difference
with 7 and 14 days of culture.
Figure 2. IL-6 release from monocytes/macrophages and
lymphocytes when in culture with (a) SEVA-C and re-
spective composites with HA and PS, (b) SPCL and re-
spective composites with HA and PLLA, (c) SCA and
respective composites with HA, for 3, 7, and 14 days. Data
represent mean 	 standard deviation, n  3. *Signiﬁcant
difference when compared with PLLA and PS. **Signiﬁ-
cant difference when compared with PLLA. 0Signiﬁcant
difference when compared with SCA. #Signiﬁcant differ-
ence when compared with SEVA-C and respective com-
posites. §Signiﬁcant difference when compared with
SEVA composites with 20% and 30% HA. ¿Signiﬁcant
difference when compared with SEVA-C  20% HA. ¤Sig-
niﬁcant difference when compared with SPCL and respec-
tive composites with 10% and 20% HA. ¢Signiﬁcant dif-
ference when compared with SPCL  20% HA.
¥Signiﬁcant difference when compared with SPCL  30%
HA. •—Signiﬁcant difference between the connected
bars.
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no inﬂuence. After 3 days of culture, the results ob-
tained for SCA were found to be different from those
obtained for composites. In addition, the results for
composites were also different from the result ob-
tained for SPCL  30% HA.
Figure 3. IL-1 release from monocytes/macrophages and
lymphocytes when in culture with (a) SEVA-C and respec-
tive composites with HA and PS, (b) SPCL and respective
composites with HA and PLLA, (c) SCA and respective
composites with HA, for 3, 7, and 14 days. Data represent
mean 	 standard deviation, n  3. *Signiﬁcant difference
when compared with PLLA and PS. **Signiﬁcant difference
when compared with PS. 0Signiﬁcant difference when com-
pared with SCA. ¢Signiﬁcant difference when compared
with SPCL 20% HA. •—Signiﬁcant difference between the
connected bars. Signiﬁcant difference with 7 and 14 days of
culture. Signiﬁcant difference with 14 days of culture.
Figure 4. TNF- release from monocytes/macrophages and
lymphocytes when in culture with (a) SEVA-C and respective
composites with HA and PS, (b) SPCL and respective composites
withHA and PLLA, (c) SCA and respective compositeswithHA,
for 3, 7, and 14 days. Data represent mean	 standard deviation,
n 3. *Signiﬁcant differencewhen comparedwith PLLA and PS.
**Signiﬁcant difference when compared with PLLA. 0Signiﬁcant
difference when compared with SCA. #Signiﬁcant difference
when comparedwith SEVA-C composites. §Signiﬁcant difference
when compared with SEVA composites with 20% and 30% HA.
¥Signiﬁcant difference when compared with SPCL  30% HA.
•—Signiﬁcant difference between the connected bars. Signiﬁ-
cant difference with 7 and 14 days of culture. Signiﬁcant differ-
ence with 14 days of culture.
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DISCUSSION
Several studies31,32 have demonstrated that leuko-
cytes attach and adhere to biomaterial surfaces. Upon
adherence, those cells undergo morphological and
physiological changes such as membrane perturbation
and frustrated phagocytosis that can lead to cell acti-
vation and the release of chemical mediators such as
cytokines.1,32–34 These cytokines can inﬂuence the ini-
tiation, duration, and resolution of the host response
to injury, which is determined by the prolonged pres-
ence of the biomaterial.35
It has been reported that there are several factors
that modulate the cellular activation process and me-
diate production of cytokines. Surface physical and
chemical properties36–38 and adhesion speciﬁc sig-
nals31,36,37 are believed to have an important role;
however, some authors39 defend that unknown factors
also might be involved in monocyte differentiation
and activation.
IL-1, TNF-, and IL-6 were considered as markers
for polymer-induced macrophage activation and it
was shown that starch-based polymers and compos-
ites signiﬁcantly reduce the release of these cytokines
compared with PS and PLLA.
It was reported by Chomyszyn-Gajewska et al.40
that in the absence of serum, PLLA did not stimulate
the release of IL-6, IL-12, and TNF-. However, after
an initial incubation with serum, the release of IL-6
and IL-12 increased dramatically, which was related to
the fact that the studied materials have no surface
ligands recognizable by macrophages to trigger the
synthesis of certain cytokines.
Activation of monocytes may occur after adhesion
to a surface, or alternatively, through cell–cell or cell–
mediator interaction without adhesion to the surface.
Studies with tissue culture PS found the greatest re-
lease of IL-1, IL-6, and TNF- by monocytes/macro-
phages cultured in contact with that polymer in com-
parison with other polymers. Ung et al.41 assumed
that the surface treatment performed in tissue culture
plates to achieve maximum adhesion leads to increas-
ing activation of monocytes/macrophages.
In the present work, cytokines were determined in
the cell supernatant, therefore the detected levels re-
ﬂected the combination of adherent and nonadherent
cells. We have previously demonstrated (article in
press)30 that the number of cells adhered to the surface
of PS was lower than in the case of certain starch-
based polymers and composites. Therefore, we may
speculate that nonadherent cells had a major contri-
bution in the production of proinﬂammatory cyto-
kines in the presence of PS.
Khouw et al.42 found that applying monoclonal an-
tibodies against IFN- inhibited the foreign body re-
action to hexamethylenediisocyanate which indicated
the important role played by that cytokine in the in-
ﬂammatory process as a well as the possibility to
modulate its activity. Some authors43 defend that mac-
rophages, besides natural killer cells and T lympho-
cytes, are also able to produce IFN-; however, T cell
inhibition results in a foreign body reaction delay
which could suggest an active role of T lymphocytes
in the host response.
Although the polymers in this study were cultured
with a mixed population of monocytes/macrophages
and lymphocytes, T cells did not demonstrate signiﬁ-
cant activation.
TNF- has a crucial role in the inﬂammatory re-
sponse, resulting in a great number of cases in osteol-
ysis around the implant.1,2,5,6 Several studies found
that this cytokine can be produced at much higher
levels than IL-6 and IL-1 by macrophages in the
presence of polymer or metal particles.44–46
The regulation of TNF- production is complex and
can be inhibited by IL-4, IL-10, or IL-13 and greatly
enhanced by IFN-. Levings and Schrader47 proved
that IL-4-mediated inhibition of TNF- release occurs
by a transcription factor STAT6-dependent mecha-
nism. However, in the presence of IFN-, another and
physiologically more important STAT6-independent
mechanism is active. In this study, no IFN- was de-
tected and the amount of produced IL-4 was similar in
the presence of all materials. Therefore, it might be
considered that IL-4 has no additional effect in the
TNF- released in the presence of the studied materi-
als.
TNF- and IL-6 were released in higher amounts
and with an almost similar distribution, which may
reﬂect monocyte differentiation, because IL-6 has been
implicated in monocyte differentiation19 and TNF-
has been described as an autocrine regulator of mac-
rophage differentiation.48
IL-1 is produced in response to many stimuli
which include bacterial lipopolysaccharide, numerous
microbial products, cytokines (TNF-, IFN-, granu-
locyte-macrophage colony-stimulating factor, and IL-
2), T cell/antigen presenting cell interactions, and im-
mune complexes and was found to stimulate the
production of IL-6 in peripheral blood monocytes.49
The IL-1 production detected was zero or minimal
in the presence of some materials, suggesting resting
or nonstimulated monocytes and macrophages. It
seems that no cross effect was happening between
TNF- release and IL-1 production or that the
amount of released TNF- was not enough to stimu-
late IL-1 production. Furthermore, the amount of
detected IL-6 was signiﬁcantly higher than the amount
of IL-1.
It has been reported that the hydrophilic/hydro-
phobic character of a polymer surface, characterized
by the contact angle, may inﬂuence cytokine produc-
tion from monocytes36; however, other factors may
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also be important, because other studies have reported
that similar compositions and contact angles result in
different IL-1 production.39 Yun et al.37 reported that
speciﬁc surfaces such as hydrophilic and neutral sur-
faces may be the least likely to adhere and activate
monocytes.
In fact, starch-based polymers have different surface
wettabilities. The more hydrophilic surfaces (SCA) in-
duced higher TNF- and IL-1 production whereas
SPCL, the polymer with the most hydrophobic sur-
face, together with SCA showed the highest secretion
of IL-6. It could be speculated that, in the case of IL-6,
hydrophilicity is not the most important factor for
monocyte/macrophage activation, whereas the TNF-
and IL-1 production seems to be dependent on and
more evident in more hydrophilic surfaces.
Protein adsorption can directly inﬂuence the activa-
tion of monocytes and macrophages on a surface in a
time-dependent manner. DeFife et al.31 found that
ﬁbrinogen and immunoglobulin G preadsorption re-
sulted in different IL-1, IL-6, and TNF- concentra-
tions in the supernatants depending on the polymers
and the time of culture. Previous studies with starch-
based polymers and human serum demonstrated that
SPCL was the polymer that presented the highest
levels of protein adsorption.50 If protein adsorption
implies cell adhesion and consequently cell activation,
the results obtained, in terms of IL-1 and TNF-
production, did not support this theory.
Concerning the HA reinforcement, although some
authors report improved performance of those im-
plants in terms of femoral remodeling and bone den-
sity,51,52 others report that ceramic coatings may pro-
duce particulate wear debris and osteolysis.53,54
Ninomiya et al.5 reported that HA enhanced the pro-
duction of IL-1, IL-6, and TNF- by human ﬁbro-
blasts in vitro. In the present study, HA resulted in a
signiﬁcant reduction of those inﬂammatory cytokines,
especially in the case of SCA and for shorter culture
periods. SEVA-C composites also showed a lower ef-
fect in the secretion of IL-6 and TNF- whereas, in the
case of SPCL composites, the only evident effect was
the secretion of TNF-; in this case, HA induced
higher production of TNF-.
CONCLUSIONS
The isolation and culture of a mixed population of
mononuclear cells enabled the evaluation of the in-
ﬂammatory potential.
Starch-based polymers and composites did not elicit
a very strong reaction from immune system cells in
vitro, demonstrated by a lower production of cyto-
kines when compared with PLLA biodegradable ma-
terial.
HA reinforcement resulted in lower cell activation,
potentially enabling better mechanical properties to be
combined with reduced levels of cytokine production.
The authors gratefully acknowledge the Portuguese Foun-
dation for Science and Technology and the Portuguese Pro-
gramme PRAXIS XXI for awarding a Ph.D. Grant to A. P.
Marques.
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